The Effects of Selenium, Resveratrol, and a Resveratrol Derivative on Human Prostate Cancer LNCaP and 22Rv1 Cell Lines

Authors

Jason Morris, Brigham Young University
Dr. Merrill J. Christensen, Brigham Young University

Keywords

selenium, resveratrol, prostate cancer, LNCaP, 22Rv1, cell lines

College

Life Sciences

Department

Nutrition, Dietetics, and Food Science

Abstract

The goal of this project was to determine whether there was a synergistic anticarcinogenic effect between selenium and resveratrol, both of which had independently demonstrated the ability to inhibit prostate cancer cell proliferation. Additionally, the project also sought to determine whether a less soluble derivative of resveratrol, synthesized at BYU by Dr. Merrit B. Andrus of the Department of Chemistry and Biochemistry, maintained the anticarcinogenic potency of resveratrol, and what were the effects of this derivative in conjunction with selenium.

Recommended Citation

Morris, Jason and Christensen, Dr. Merrill J. (2013) "The Effects of Selenium, Resveratrol, and a Resveratrol Derivative on Human Prostate Cancer LNCaP and 22Rv1 Cell Lines," Journal of Undergraduate Research: Vol. 2013: Iss. 1, Article 1373.
Available at: https://scholarsarchive.byu.edu/jur/vol2013/iss1/1373